Simple blood test could better predict which kidney disease patients will die

Researchers have identified a new mortality predictor for end-stage kidney disease patients using a straightforward measurement of two existing blood markers. The finding could help dialysis centers and nephrologists identify high-risk patients earlier and adjust treatment strategies, potentially improving outcomes and reducing unexpected deaths in this vulnerable population.

Originaltitel: Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients